| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 1,340,100 | 1,593,100 | ||
| Marketable investments | 1,427,500 | 1,455,600 | ||
| Accounts receivable, no allowance for 2025 and 2024 | 297,700 | 379,300 | ||
| Inventories, net | 176,500 | 169,200 | ||
| Other current assets | 252,200 | 229,700 | ||
| Total current assets | 3,494,000 | 3,826,900 | ||
| Marketable investments | 1,567,300 | 1,917,700 | ||
| Goodwill and other intangible assets, net | 116,700 | 111,500 | ||
| Property, plant, and equipment, net | 1,555,600 | 1,362,400 | ||
| Deferred tax assets, net | 354,900 | 456,200 | ||
| Other non-current assets | 262,600 | 233,300 | ||
| Total assets | 7,351,100 | 7,908,000 | ||
| Accounts payable and accrued expenses | 468,000 | 432,000 | ||
| Line of credit | 0 | 0 | ||
| Other current liabilities | 78,300 | 95,100 | ||
| Total current liabilities | 546,300 | 527,100 | ||
| Other non-current liabilities | 214,600 | 207,300 | ||
| Total liabilities | 760,900 | 734,400 | ||
| Preferred stock, par value .01, 10,000,000 shares authorized, no shares issued | 0 | 0 | ||
| Common stock, par value .01, 245,000,000 shares authorized, 75,708,024 and 74,997,896 shares issued, and 42,902,818 and 44,831,306 shares outstanding as of september30, 2025 and december31, 2024, respectively | 800 | 800 | ||
| Additional paid-in capital | 2,658,700 | 2,793,400 | ||
| Accumulated other comprehensive income (loss) | 100 | 0 | ||
| Treasury stock, 32,805,206 and 30,166,590 shares as of september30, 2025 and december31, 2024, respectively | 4,262,000 | 3,474,500 | ||
| Retained earnings | 8,192,600 | 7,853,900 | ||
| Total stockholders equity | 6,590,200 | 7,173,600 | ||
| Total liabilities and stockholders equity | 7,351,100 | 7,908,000 | ||
UNITED THERAPEUTICS Corp (UTHR)
UNITED THERAPEUTICS Corp (UTHR)